GCC Biopsy Devices Market

GCC Biopsy Devices Market Overview:

The GCC biopsy devices market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028. Biopsy devices are used to remove tissue from an organ to examine it for disease and determine the presence of cancerous cells. These devices include forceps, localization wires, aspiration needles, syringes, vacuum-assisted devices (VAD), sponges, scalpels, and a specimen cup or microscope slide. They are used to perform endoscopic, lymph node, muscle, nerve, skin, lung, kidney, breast, liver, bone marrow, testicular, thyroid, and surgical biopsies. They are employed with imaging guidance such as magnetic resonance imaging (MRI), computed tomography (CT), x-ray, fine-needle aspiration, and ultrasound. At present, biopsy devices are widely used by surgeons, cardiologists, radiologists, hospitals, and research centers across the GCC region.

The market is primarily driven by the increasing prevalence of cancer across the GCC region. In addition, the improving healthcare infrastructure and the escalating demand for effective diagnostic procedures are contributing to market growth. Moreover, government authorities in the region are introducing medical schemes and policies to support the deployment of biopsy devices and spread awareness about cancer among individuals, which represents another major growth-inducing factor. Besides this, the growing preference for minimally invasive surgeries (MIS) and disposable biopsy devices is also augmenting the market growth. Along with this, various technological advancements, such as the development of needle-based biopsy guns, 3D optical biopsies, biopsy guidance systems, ultrasound-guided biopsy, magnetic resonance imaging (MRI) targeted biopsy, and vacuum-assisted guns, are providing a positive thrust to the market growth. Apart from this, the increasing investments in research and development (R&D) activities to launch various novel equipment, such as robotic medical systems, that increase the total number of surgeries and reduce the patient stay in the hospital are creating a favorable market outlook across the GCC region. Furthermore, the surging need for needle-based biopsy instruments for acquiring samples of soft tissues is also propelling the market growth across the GCC region.

Beginning with a regional overview, the report explores the dynamics that have a strong influence on the GCC biopsy devices market and can also impact its future growth. Taking 2022 as the base year, the report covers historical market scenario from 2017-2022 and provides forecasts till 2027. This includes the study of value and volume trends and pricing history. Growth inducing factors, market restraints and recent developments have also been analysed in the report in order to provide a deeper knowledge about the industry. On a regional basis, the report examines the GCC biopsy devices market in Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. For each of these regions, the report studies the GCC biopsy devices market in detail for latest trends, outlook and opportunities.

The report analyses the competitive structure of the GCC biopsy devices market industry and provides the profiles of major players operating in the market. The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the GCC biopsy devices market industry along the parameters of the Porter’s Five Forces model. This model examines the degree of competition in the GCC biopsy devices market industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. SWOT analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the GCC biopsy devices market industry. Furthermore, the value chain analysis of the GCC biopsy devices market industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing, sales and distribution. 

GCC Biopsy Devices Market Segment Insights:

The GCC biopsy devices market has been analysed as followed:

By Procedure Type:

• Surgical Biopsy
• Needle Biopsy

By Product:

• Biopsy Guidance Systems
• Needle Based Biopsy Guns
• Biopsy Needles
• Biopsy Forceps
• Others

By Application:

• Breast Biopsy
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others

By Guidance Technique:

• Ultrasound-guided Biopsy
• Stereotactic-guided Biopsy
• MRI-guided Biopsy
• Others

By End User:

• Hospitals and Clinics
• Academic and Research Institutes
• Others

By Country:

• Saudi Arabia
• United Arab Emirates
• Qatar
• Kuwait
• Oman
• Bahrain

Country-wise, the market has been segmented into Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. Amongst these, Saudi Arabia represents the largest market, accounting for majority of the GCC region.

Competative Landscape: 

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Highlights of the GCC Biopsy Devices Market Report:

• Historical and current scenario
• Trends and developments
• Impact of COVID-19
• Market forecast
• Price analysis and forecast
• Porter’s five forces analysis
• SWOT analysis
• Value chain analysis

Report Customisation:

The GCC biopsy devices market report can be customised as per your requirements. You can get in touch with our analyst, who will make sure that the report suits your research needs